Patent US4363327A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4363327A Expired / Lapsed US ⏱️ 0.0 years remaining

Cyclic injection method for continuous measurements of pulmonary parameters

Assignee: Intermountain Healthcare
•
Filing: 1980-08-22
•
Granted: 1982-12-14
•
Expires: 2000-08-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A non-invasive cyclic injection method for determining pulmonary blood flow, the ventilation-perfusion distribution and functional residual capacity, which consists of the non-invasive cyclical introduction of soluble and insoluble inert gases into the airstream of the human patient, each period of introduction followed by a similar period free from the introduction of soluble inert gases to allow for the washout of their concentrated buildup in the venous system. Sampling and analysis of expired air during all parts of the cyclic injection and non-injection of gases takes place with the results being electronically obtained and translated into digital data indicative of the parameter being determined.

Inventors

  • 👤 Justin S. Clark

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 11:17
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/08; A61B5/0813; G; G01; G01F; G01F1/00; G01F1/704

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 219 words
In a method of sampling and analyzing alveolar air is a human subject without requiring an airtight seal between the subject and monitoring equipment to determine alveolar ventilation by means of injecting a known amount of an insoluble inert tracer gas into the airway of a subject by non-airtight means, during inspiration and directly sampling expired alveolar air by non-airtight means and monitoring the inert tracer gas concentration in expired air under steady state conditions to determine alveolar ventilation, the improvement which consists of determining additional pulmonary parameters, comprising the steps of: (a) directly introducing the known amount of insoluble inert tracer gas during each inspiratory cycle for a given period of time designated as a washin cycle and then halting the introduction of such gas for a given period of time designated as a washout cycle, (c) simultaneous with the introduction of the insoluble tracer gas, introducing one or more additional tracer gases which are at least partially soluble in blood for the same washing cycle and then halting the introduction of said soluble tracer gas or gases for the same washout cycle, (c) continuously repeating said washin and washout cycles and sampling and monitoring the insoluble and soluble gas fractions in sampled expired alveolar air, and (d) utilizing the monitored data to determine the desired pulmonary parameter.
Claim 2
Dependent Claim 219 words
In a method of sampling and analyzing alveolar air is a human subject without requiring an airtight seal between the subject and monitoring equipment to determine alveolar ventilation by means of injecting a known amount of an insoluble inert tracer gas into the airway of a subject by non-airtight means, during inspiration and directly sampling expired alveolar air by non-airtight means and monitoring the inert tracer gas concentration in expired air under steady state conditions to determine alveolar ventilation, the improvement which consists of determining additional pulmonary parameters, comprising the steps of: (a) directly introducing the known amount of insoluble inert tracer gas during each inspiratory cycle for a given period of time designated as a washin cycle and then halting the introduction of such gas for a given period of time designated as a washout cycle, (c) simultaneous with the introduction of the insoluble tracer gas, introducing one or more additional tracer gases which are at least partially soluble in blood for the same washing cycle and then halting the introduction of said soluble tracer gas or gases for the same washout cycle, (c) continuously repeating said washin and washout cycles and sampling and monitoring the insoluble and soluble gas fractions in sampled expired alveolar air, and (d) utilizing the monitored data to determine the desired pulmonary parameter.
Claim 3
Dependent Claim 40 words
A method according to claim 1 wherein the sampled expired alveolar gases are monitored by means which create electronic signals which signals are relayed to translation means which convert said signals into visual values which indicate the desired pulmonary parameter.
Claim 4
Dependent Claim 24 words
A method according to claim 2 wherein the given period of time for each washin and washout cycle is a predetermined number of breaths.
Claim 5
Dependent Claim 41 words
A method according to claim 3 wherein the washin and washout cycles are continued for a multiplicity of cycles and wherein the monitored data is averaged over a given number of cycles before being utilized in determining the desired pulmonary parameters.
Claim 6
Dependent Claim 44 words
A method according to claim 4 wherein the said one or more gases which are at least partially soluble in blood are selected from the group consisting of ethane, methane, acetylene, nitrous oxide, methyl chloride, halothane, fluroxene, dimethylether, acetone, dichlorodifluoromethane, monochlorodifluoromethane and mixtures thereof.
Claim 7
Dependent Claim 20 words
A method according to claim 5 wherein a single gas, which is at least partially soluble in blood, is used.
Claim 8
Dependent Claim 21 words
A method according to claim 5 wherein a multiplicity of gases which are at least partially soluble in blood are used.
Claim 9
Dependent Claim 24 words
A method according to claim 5 wherein the pre-determined number of breaths during the washin and washout cycles is between 1 and 30 inclusive.
Claim 10
Dependent Claim 25 words
A method according to claim 5 wherein the insoluble gas is a member selected from the group consisting of helium, argon, sulfurhexafluoride and carbon tetrafluoride.
Claim 11
Independent Claim 170 words
A method for determining the ventilation-perfusion distribution in a human subject which comprises: a. directly introducing a gaseous mixture of tracer gases into the airway of said subject during each inspiratory cycle for a given period of time designated as a washin cycle and then halting the introduction of such mixture for a given period of time designated as a washout cycle, said gas consisting of one inert tracer gas which is relatively insoluble in blood and one or more inert tracer gases which are at least partially soluble in blood wherein the ratio of each soluble gas to the insoluble gas is known, b. continuously repeating said washin and washout cycles, c. sampling expired alveolar air from each cycle and monitoring the one or more ratios of said one or more soluble tracer gases to insoluble tracer gas in the sampled expired alveolar air, and d. utilizing the monitored data obtained from sampled alveolar air along with the known ratios of tracer gases cyclically introduced to determine ventilation-perfusion distribution.
Claim 12
Independent Claim 170 words
A method for determining the ventilation-perfusion distribution in a human subject which comprises: a. directly introducing a gaseous mixture of tracer gases into the airway of said subject during each inspiratory cycle for a given period of time designated as a washin cycle and then halting the introduction of such mixture for a given period of time designated as a washout cycle, said gas consisting of one inert tracer gas which is relatively insoluble in blood and one or more inert tracer gases which are at least partially soluble in blood wherein the ratio of each soluble gas to the insoluble gas is known, b. continuously repeating said washin and washout cycles, c. sampling expired alveolar air from each cycle and monitoring the one or more ratios of said one or more soluble tracer gases to insoluble tracer gas in the sampled expired alveolar air, and d. utilizing the monitored data obtained from sampled alveolar air along with the known ratios of tracer gases cyclically introduced to determine ventilation-perfusion distribution.
Claim 13
Dependent Claim 40 words
A method according to claim 10 wherein the sampled expired alveolar gases are monitored by means which create electronic signals which signals are relayed to translation means which convert said signals into visual values which indicate the desired pulmonary parameter.
Claim 14
Dependent Claim 24 words
A method according to claim 11 wherein the given period of time for each washin and washout cycle is a predetermined number of breaths.
Claim 15
Dependent Claim 40 words
A method according to claim 12 wherein the washin and washout cycles are continued for a multiplicity of cycles and wherein the monitored data is averaged over a given number of cycles before being utilized in determining the ventilation-perfusion distribution.
Claim 16
Dependent Claim 44 words
A method according to claim 13 wherein the said one or more gases which are at least partially soluble in blood are selected from the group consisting of ethane, methane, acetylene, nitrous oxide, methyl chloride, halothane, fluroxene, dimethylether, acetone, dichlorodifluoromethane, monochlorodifluoromethane and mixtures thereof.
Claim 17
Dependent Claim 21 words
A method according to claim 14 wherein a multiplicity of gases which are at least partially soluble in blood are used.
Claim 18
Dependent Claim 23 words
A method according to claim 15 wherein predetermined number of breaths during the washin and washout cycles is between 1 and 30 inclusive.
Claim 19
Dependent Claim 25 words
A method according to claim 14 wherein the insoluble tracer gas is selected from the group consisting of helium, argon, sulfur hexafluoride, and carbon tetrafluoride.

References Cited (Backward Citations)

US3622059A Cited
US4034743A Cited
US4083367A Cited
US4169465A Cited
US4301729A Cited
US4221224A Cited
US4207818A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-12-13 1986-06-14 1986-12-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-12-13 1990-06-14 1990-12-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-12-13 1994-06-14 1994-12-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag